Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ UQCRFS1 Polyclonal Antibody

Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA521420
Description
Recommended positive controls: Raji, mouse brain. Predicted reactivity: Mouse (90%), Rat (91%), Bovine (89%). Store product as a concentrated solution. Centrifuge briefly prior to opening the vial.
Component of the ubiquinol-cytochrome c reductase complex (complex III or cytochrome b-c1 complex), which is a respiratory chain that generates an electrochemical potential coupled to ATP synthesis.
Specifications
| UQCRFS1 | |
| Polyclonal | |
| Unconjugated | |
| Uqcrfs1 | |
| 4430402G14Rik; 8 kDa subunit 9; AI875505; Complex III subunit 5; Complex III subunit IX; Cytochrome b-c1 complex subunit 11; Cytochrome b-c1 complex subunit 5; Cytochrome b-c1 complex subunit 9; Cytochrome b-c1 complex subunit Rieske, mitochondrial; liver regeneration-related protein LRRGT00195; LRRGT00195; Rieske iron-sulfur protein; Rieske protein UQCRFS1; RIP1; RIS1; RISP; Su9; Ubiquinol-cytochrome c reductase 8 kDa protein; Ubiquinol-cytochrome c reductase iron-sulfur subunit; ubiquinol-cytochrome c reductase, Rieske iron-sulfur polypeptide 1; UQCR5; UQCRFS1 | |
| Rabbit | |
| Antigen affinity chromatography | |
| RUO | |
| 66694, 7386 | |
| Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
| Liquid |
| Western Blot, Immunocytochemistry | |
| 0.32 mg/mL | |
| 0.1M tris glycine with 10% glycerol and 0.01% thimerosal; pH 7 | |
| P47985, Q9CR68 | |
| Uqcrfs1 | |
| Recombinant protein encompassing a sequence within the center region of human UQCRFS1. The exact sequence is proprietary. | |
| 100 μL | |
| Primary | |
| Human, Mouse | |
| Antibody | |
| IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction